Executive Director, Global Value & Access Therapeutic Area Lead, HIV & Emerging Viruses

• Lead an industry-leading team to develop and execute robust global value and access strategies across the HIV&EV therapeutic area (TA), including setting clear direction for planning and implementation, creating V&A objectives, coordinating strategies across assets, and providing guidance and input for all key V&A deliverables.


• Oversee the generation of the global V&A strategy, integrated evidence plans, value story, and stakeholder engagement planning for TA-specific assets in both HIV & EV (EV focus are medicines to treat COVID-19).


• Partner with Global Strategy Marketing (GSM) TA Lead to ensure alignment of V&A strategy with the global brand strategy.


• Ensure collaboration with cross-functional partners (Clin Dev, Medical Affairs, Government Affairs, and other global and local commercial counterparts) to develop a comprehensive TA strategy and business priorities.


• Represent TA from a V&A perspective, providing a comprehensive view of the global priority Affiliates (G9) to the team and cross-functional partners, including Clin Dev, and ensuring the payer perspective is reflected in the overall product commercial and development strategy


• Guide the development and implementation of global value and access strategies for TA-specific assets throughout the product lifecycle, from pre-clinical to post-launch, drawing on health economics, pricing models, payer landscapes and global evidence requirements to maximize product value and patient access.


• Deliver strategic leadership as an active member of GV&A's leadership team (LT) and the HIV Franchise cross-functional LT, shaping the team's strategy, priorities, and activities.

• Required: Bachelor's degree and a minimum of 16 years' experience in the biotech or pharmaceutical industry in market access-related activities or an advanced degree and minimum of 14 years' experience (including experience with global and in-country market access)


• Preferred: MBA and/or advanced degree in life sciences or medical degree


• Broad therapeutic-area knowledge of HIV is a value-add


• Global experience working with (or in) multiple key markets, including regional, as well as country-specific regulatory systems and global health systems.


• Deep understanding of global payer environment, including coverage and reimbursement, pricing and contracting, formulary management, HTA and payment policy.


• Expertise in strategic pricing, contracting and negotiation, including innovative approaches and experience developing pricing strategies and business cases.


• Advanced understanding of the pharmaceutical product lifecycle, including experience with market access launch planning, execution, and drivers of value.


• Significant experience developing global V&A strategies, including developing global value messages, integrated evidence planning and creating tools to support implementation in key markets.


• Experience with early-stage assets, including conducting commercialization assessments and providing V&A guidance into target product profiles and development plans.


• Proven track record managing a high-performing team, building a distinctive team culture in a globally dispersed team, and developing people through coaching and mentoring.


• Demonstrated ability to lead and influence cross-functionally, while also serving as a highly-skilled facilitator, negotiator, and counselor.